Can Isolated Head Tremors Be an Extrapyramidal Symptom Associated with Lurasidone?-A Case Series.
作者信息
Simiyon Manjula, Thilakan Pradeep, Topno Isabella
机构信息
Dept. of Pharmacology, Pondicherry Institute of Medical Sciences, Kalapet, Pondicherry 605014, India.
Betsi Cadwaldr University Health Board, Wrexham LL13 7TD, United Kingdom.
出版信息
Indian J Psychol Med. 2021 Nov;43(6):546-548. doi: 10.1177/02537176211010505. Epub 2021 Jun 2.
Abstract
摘要
相似文献
1
Can Isolated Head Tremors Be an Extrapyramidal Symptom Associated with Lurasidone?-A Case Series.孤立性头部震颤会是与鲁拉西酮相关的锥体外系症状吗？——病例系列
Indian J Psychol Med. 2021 Nov;43(6):546-548. doi: 10.1177/02537176211010505. Epub 2021 Jun 2.
2
Lurasidone-induced anemia: Is there a need for hematological monitoring?鲁拉西酮致贫血：是否需要进行血液学监测？
Indian J Pharmacol. 2019 Jul-Aug;51(4):276-278. doi: 10.4103/ijp.IJP_434_18.
3
A missed case of lurasidone induced laryngospasm: A case study and overview of extrapyramidal symptom identification and treatment.漏诊的鲁拉西酮诱发的喉痉挛：病例研究及锥体外系症状识别与治疗概述。
Int J Psychiatry Med. 2021 Mar;56(2):73-82. doi: 10.1177/0091217420943786. Epub 2020 Jul 13.
4
Extrapyramidal effects of acute organophosphate poisoning.急性有机磷中毒的锥体外系效应
Clin Toxicol (Phila). 2016 Mar;54(3):259-65. doi: 10.3109/15563650.2015.1126841. Epub 2016 Jan 6.
5
Lurasidone: a new treatment option for schizophrenia.鲁拉西酮：精神分裂症的一种新治疗选择。
Drugs Today (Barc). 2011 Nov;47(11):807-16. doi: 10.1358/dot.2011.47.11.1708832.
6
Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?鲁拉西酮所致血小板减少症：它是药物性骨髓抑制的信号吗？
Indian J Psychol Med. 2018 Mar-Apr;40(2):191-192. doi: 10.4103/IJPSYM.IJPSYM_374_17.
7
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.在精神分裂症和双相情感障碍的治疗中，阿塞那平、依匹哌酮、鲁拉西酮和帕利哌酮的体重和代谢不良影响：系统评价和探索性荟萃分析。
CNS Drugs. 2012 Sep 1;26(9):733-59. doi: 10.2165/11634500-000000000-00000.
8
[Long-term efficacy and safety of lurasidone in the treatment of schizophrenia].鲁拉西酮治疗精神分裂症的长期疗效与安全性
Encephale. 2015 Dec;41(6):541-9. doi: 10.1016/j.encep.2015.09.005.
9
Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.新型抗精神病药物鲁拉西酮的药理学特性，其对 5-羟色胺 7（5-HT7）受体和 5-羟色胺 1A（5-HT1A）受体具有强大的活性。
J Pharmacol Exp Ther. 2010 Jul;334(1):171-81. doi: 10.1124/jpet.110.167346. Epub 2010 Apr 19.
10
[Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].鲁拉西酮治疗精神分裂症的短期疗效与安全性
Encephale. 2014 Dec;40(6):507-17. doi: 10.1016/j.encep.2014.10.009.
本文引用的文献
1
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis.32 种口服抗精神病药治疗反复发作性精神分裂症成人患者的急性疗效和耐受性的比较：系统评价和网络荟萃分析。
Lancet. 2019 Sep 14;394(10202):939-951. doi: 10.1016/S0140-6736(19)31135-3. Epub 2019 Jul 11.
2
Lurasidone-induced Parkinsonism and Hyperprolactinemia.
Indian J Psychol Med. 2019 Mar-Apr;41(2):192-194. doi: 10.4103/IJPSYM.IJPSYM_274_18.
3
Severe Extrapyramidal Syndrome Caused by Lurasidone Low Dose.低剂量鲁拉西酮引起的严重锥体外系综合征
J Neurosci Rural Pract. 2018 Jul-Sep;9(3):446-448. doi: 10.4103/jnrp.jnrp_571_17.
4
Transient, Isolated Head Tremor in "Unaffected" Individuals: Is Essential Tremor an Even More Prevalent Disease Than We Suppose?“未受影响”个体中的短暂性、孤立性头部震颤：原发性震颤是否是一种比我们想象中更为普遍的疾病？
Front Neurol. 2018 Jul 13;9:570. doi: 10.3389/fneur.2018.00570. eCollection 2018.
5
Lurasidone-Induced Rabbit Syndrome: A Case Report.鲁拉西酮所致兔综合征：一例报告
J Clin Psychiatry. 2017 May;78(5):e553. doi: 10.4088/JCP.16cr11157.
6
Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile.鲁拉西酮：2016年药理学、疗效及安全性概况更新
Pharmacol Rep. 2016 Aug;68(4):748-55. doi: 10.1016/j.pharep.2016.04.002. Epub 2016 Apr 22.
7
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study.鲁拉西酮治疗精神分裂症的长期安全性和有效性：一项为期22个月的开放标签扩展研究。
CNS Spectr. 2016 Oct;21(5):393-402. doi: 10.1017/S1092852915000917. Epub 2016 Apr 6.
8
Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study.鲁拉西酮对从其他抗精神病药物转换过来的精神分裂症或精神分裂症-情感障碍患者的有效性：一项为期6个月的开放标签延长期研究。
CNS Spectr. 2014 Aug;19(4):330-9. doi: 10.1017/S109285291300093X. Epub 2013 Dec 16.
9
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.15 种抗精神分裂症药物的疗效和耐受性比较：一项多治疗荟萃分析。
Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27.
10
Determination of dopamine D₂ receptor occupancy by lurasidone using positron emission tomography in healthy male subjects.使用正电子发射断层扫描技术在健康男性受试者中测定鲁拉西酮对多巴胺 D₂ 受体的占有率。
Psychopharmacology (Berl). 2013 Sep;229(2):245-52. doi: 10.1007/s00213-013-3103-z. Epub 2013 May 7.
Zotero 插件